Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathological Evolution and Internal Medicine Management of Nonalcoholic Fatty Liver Disease (NAFLD) in the Era of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). | Cureus | 2025 | 40734888 | PubTator, text mining | PubMed |
| High-Risk PNPLA3 rs738409 Genotype Is Associated with Higher Concentrations of CCL2 in Liver Transplant Candidates with Alcoholic End-Stage Liver Disease. | Medicina (Kaunas) | 2025 | 40731922 | PubTator, text mining | PubMed |
| The Distribution and Survival Association of Genetic Polymorphisms in Thai Patients with Hepatocellular Carcinoma According to Underlying Liver Disease. | Genes (Basel) | 2025 | 40725464 | PubTator, text mining | PubMed |
| The PNPLA3 I148M variant is associated with immune cell infiltration and advanced fibrosis in MASLD: a prospective genotype-phenotype study. | J Gastroenterol | 2025 | 40691355 | PubTator, text mining | PubMed |
| Genetic variants influencing liver fat in normal-weight individuals of European ancestry. | JHEP Rep | 2025 | 40677695 | PubTator, text mining | PubMed |
| PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feeding. | JHEP Rep | 2025 | 40677694 | PubTator, text mining | PubMed |
| PNPLA3 I148M variant is the main driver of weight gain after hepatitis C cure. | Sci Rep | 2025 | 40665131 | PubTator, text mining | PubMed |
| Polymorphism's MBOAT7 as Risk and MTARC1 as Protection for Liver Fibrosis in MASLD. | Int J Mol Sci | 2025 | 40650184 | PubTator, text mining | PubMed |
| Advancing Personalized Nutrition Through Genetic Nutritional Insights. | Nutrients | 2025 | 40647271 | PubTator, text mining | PubMed |
| Underlining the Molecular Mechanism of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease in Lipid Metabolism by Combining Multiple Sets of Data Sets. | IUBMB Life | 2025 | 40631874 | PubTator, text mining | PubMed |
| Extrahepatic Events in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and the Impact of Genetics and Alcohol Intake. | Hepatol Res | 2025 | 40590763 | PubTator, text mining | PubMed |
| Therapeutic horizons in metabolic dysfunction-associated steatohepatitis. | J Clin Invest | 2025 | 40590228 | PubTator, text mining | PubMed |
| MASLD in children: integrating epidemiological trends with mechanistic and translational advances. | J Clin Invest | 2025 | 40590222 | PubTator, text mining | PubMed |
| The ameliorative effect of C-Kit+ hepatic endothelial cells with Mertk deficiency on nonalcoholic steatohepatitis. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40582627 | PubTator, text mining | PubMed |
| Meta-Analysis: Effects of Steatotic Liver Disease-Associated Genetic Risk Alleles on Longitudinal Outcomes. | Aliment Pharmacol Ther | 2025 | 40580198 | PubTator, text mining | PubMed |
| A Defective Circulating Mitochondrial Bioenergetics Profile Reflects the Hepatic One and Outlines Genetic MASLD. | Antioxidants (Basel) | 2025 | 40563253 | PubTator, text mining | PubMed |
| Procoagulant imbalance is associated with hepatic and vascular complications in patients with MASLD and diabetes. Key role of factor VIII. | Dig Liver Dis | 2025 | 40541512 | PubTator, text mining | PubMed |
| Editorial: Next generation micro-physiological systems for pragmatic use in regular industrial workflow. | Front Cell Dev Biol | 2025 | 40510744 | PubTator, text mining | PubMed |
| Polygenic Risk Score for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Narrative Review. | Int J Mol Sci | 2025 | 40507973 | PubTator, text mining | PubMed |
| MetALD: Genetic Factors and Clinical Outcomes. | Semin Liver Dis | 2025 | 40489997 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=13